Search Results

There are 30220 results for: content related to: Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform

  1. Five Un-Easy Pieces of Pharmaceutical Policy Reform

    The Journal of Law, Medicine & Ethics

    Volume 41, Issue 3, Fall 2013, Pages: 581–589, Marc A. Rodwin

    Version of Record online : 1 OCT 2013, DOI: 10.1111/jlme.12067

  2. Rooting Out Institutional Corruption to Manage Inappropriate Off-Label Drug Use

    The Journal of Law, Medicine & Ethics

    Volume 41, Issue 3, Fall 2013, Pages: 654–664, Marc A. Rodwin

    Version of Record online : 1 OCT 2013, DOI: 10.1111/jlme.12075

  3. Reforming Pharmaceutical Industry-Physician Financial Relationships: Lessons from the United States, France, and Japan

    The Journal of Law, Medicine & Ethics

    Volume 39, Issue 4, Winter 2011, Pages: 662–670, Marc A. Rodwin

    Version of Record online : 15 NOV 2011, DOI: 10.1111/j.1748-720X.2011.00633.x

  4. Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs

    The Journal of Law, Medicine & Ethics

    Volume 41, Issue 3, Fall 2013, Pages: 590–600, Donald W. Light, Joel Lexchin and Jonathan J. Darrow

    Version of Record online : 1 OCT 2013, DOI: 10.1111/jlme.12068

  5. Drug Firms, the Codification of Diagnostic Categories, and Bias in Clinical Guidelines

    The Journal of Law, Medicine & Ethics

    Volume 41, Issue 3, Fall 2013, Pages: 644–653, Lisa Cosgrove and Emily E. Wheeler

    Version of Record online : 1 OCT 2013, DOI: 10.1111/jlme.12074

  6. Drug Advertising, Continuing Medical Education, and Physician Prescribing: A Historical Review and Reform Proposal

    The Journal of Law, Medicine & Ethics

    Volume 38, Issue 4, Winter 2010, Pages: 807–815, Marc A. Rodwin

    Version of Record online : 24 NOV 2010, DOI: 10.1111/j.1748-720X.2010.00534.x

  7. INTRODUCTION: Institutional Corruption and the Pharmaceutical Policy

    The Journal of Law, Medicine & Ethics

    Volume 41, Issue 3, Fall 2013, Pages: 544–552, Marc A. Rodwin

    Version of Record online : 1 OCT 2013, DOI: 10.1111/jlme.12062

  8. Toward a Jurisprudence of Drug Regulation

    The Journal of Law, Medicine & Ethics

    Volume 42, Issue 2, Summer 2014, Pages: 244–262, Matthew Herder

    Version of Record online : 16 JUL 2014, DOI: 10.1111/jlme.12139

  9. Pharmaceuticals, Political Money, and Public Policy: A Theoretical and Empirical Agenda

    The Journal of Law, Medicine & Ethics

    Volume 41, Issue 3, Fall 2013, Pages: 561–570, Paul D. Jorgensen

    Version of Record online : 1 OCT 2013, DOI: 10.1111/jlme.12065

  10. Curbing Misconduct in the Pharmaceutical Industry: Insights from Behavioral Ethics and the Behavioral Approach to Law

    The Journal of Law, Medicine & Ethics

    Volume 41, Issue 3, Fall 2013, Pages: 620–628, Yuval Feldman, Rebecca Gauthier and Troy Schuler

    Version of Record online : 1 OCT 2013, DOI: 10.1111/jlme.12071

  11. Privacy and Health Information Technology

    The Journal of Law, Medicine & Ethics

    Volume 37, Issue s2, Fall 2009, Pages: 121–149, Deven McGraw

    Version of Record online : 28 AUG 2009, DOI: 10.1111/j.1748-720X.2009.00424.x

  12. The Metamorphosis of Managed Care: Implications for Health Reform Internationally

    The Journal of Law, Medicine & Ethics

    Volume 38, Issue 2, Summer 2010, Pages: 352–364, Marc A. Rodwin

    Version of Record online : 21 JUN 2010, DOI: 10.1111/j.1748-720X.2010.00494.x

  13. Recent Developments in Health Law

    The Journal of Law, Medicine & Ethics

    Volume 26, Issue 1, March 1998, Pages: 68–78,

    Version of Record online : 5 JUN 2007, DOI: 10.1111/j.1748-720X.1998.tb01908.x

  14. Recent Developments in Health Law

    The Journal of Law, Medicine & Ethics

    Volume 33, Issue 2, June 2005, Pages: 384–403,

    Version of Record online : 24 JAN 2007, DOI: 10.1111/j.1748-720X.2005.tb00505.x

  15. Challenges in the Federal Regulation of Pain Management Technologies

    The Journal of Law, Medicine & Ethics

    Volume 31, Issue 1, March 2003, Pages: 55–74, Lars Noah

    Version of Record online : 24 JAN 2007, DOI: 10.1111/j.1748-720X.2003.tb00059.x

  16. Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won't Cast Light On

    The Journal of Law, Medicine & Ethics

    Volume 41, Issue 3, Fall 2013, Pages: 635–643, Sergio Sismondo

    Version of Record online : 1 OCT 2013, DOI: 10.1111/jlme.12073

  17. Corruption of Pharmaceutical Markets: Addressing the Misalignment of Financial Incentives and Public Health

    The Journal of Law, Medicine & Ethics

    Volume 41, Issue 3, Fall 2013, Pages: 571–580, Marc-André Gagnon

    Version of Record online : 1 OCT 2013, DOI: 10.1111/jlme.12066

  18. PPACA and Public Health: Creating a Framework to Focus on Prevention and Wellness and Improve the Public's Health

    The Journal of Law, Medicine & Ethics

    Volume 39, Issue 3, Fall 2011, Pages: 366–379, Gwendolyn Roberts Majette

    Version of Record online : 22 AUG 2011, DOI: 10.1111/j.1748-720X.2011.00606.x

  19. Quality Control in Health Care: Developments in the Law of Medical Malpractice

    The Journal of Law, Medicine & Ethics

    Volume 21, Issue 2, June 1993, Pages: 173–192, Barry R. Furrow

    Version of Record online : 5 JUN 2007, DOI: 10.1111/j.1748-720X.1993.tb01241.x

  20. The Ethics of Pharmaceutical Research Funding: A Social Organization Approach

    The Journal of Law, Medicine & Ethics

    Volume 41, Issue 3, Fall 2013, Pages: 629–634, Garry C. Gray

    Version of Record online : 1 OCT 2013, DOI: 10.1111/jlme.12072